Get the Weekly Intelligence Brief — top committee picks every Sunday.
PHG · NYSE · STOCK

Koninklijke Philips (PHG) Stock Analysis

Healthcare Updated October 10, 2026
$24.24
52W $23.62 – $33.44
58/100
$23.69B
18.6
0.92
AI Committee Verdict
Buy
58/100
Conviction: Moderate · 60% agreement · 5 analysts
+6.6%
-1.6%
4.28:1
Moderate

Is PHG Bullish or Bearish?

Bullish. Innellis AI committee rates Koninklijke Philips N.V. (PHG) Buy with a composite score of 58/100 , based on 5 analysts with 60% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +17.15 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -2.85 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 604.9% yoy. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Dividend yield of 4.2% pays you to wait — Value
  • EPS growing 604.9% YoY — Growth
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Revenue declining -1.1% YoY -- this is not a growth story right now — Growth
  • Price structure making lower highs and lower lows — Technical
  • Trend and market structure agree -- coherent bearish picture — Technical
  • Daily trend (downtrend) conflicts with the weekly trend (uptrend) -- fighting the larger trend — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
58/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 46%
of 192 Healthcare peers
Value Analyst neutral
58 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 4.2% pays you to wait
Growth Analyst bullish
66 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 604.9% YoY
− Revenue declining -1.1% YoY -- this is not a growth story right now
Technical Analyst neutral
46 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
54 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 59.3 to 57.9.

Analyst-level changes:
  • News Analyst: stance bullish->neutral; score 62->54 (-7).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
43.7
Neutral
MACD Histogram
0.037
Bullish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$23.86
Resistance
$25.85
Bollinger %B
0.32
Inside Bands
Price vs Moving Averages
EMA 9
$24.26 Below
EMA 21
$24.64 Below
EMA 50
$25.38 Below
EMA 200
$26.64 Below

Fundamental Analysis

Valuation
94
Growth
81
Profitability
43
Financial Health
65
Cash Flow
70
Valuation
P/E Ratio 18.6×
P/B Ratio 1.82×
PEG Ratio 0.03
Dividend Yield 3.90%
52W High $33.44
52W Low $23.62
Quality & Growth
ROE 816.8%
ROA 332.2%
Gross Margin 4593.0%
Operating Margin 1016.8%
Revenue Growth YoY —
Debt / Equity 0.65
AI Fundamental Assessment
P/E ratio of 18.6 (inexpensive relative to a 15-40x range); Price-to-book of 1.8x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 8.2%; Return on assets of 3.3%; Net margin of 6.3%; Gross margin of 45.9%; Current ratio of 1.26 (tight short-term liquidity); Debt-to-equity of 0.65; Free cash flow per share is positive (1.99); Most recent quarter beat estimates by 36.7%; 4 consecutive earnings beats; EPS growth accelerating (-54.0% -> +113.0% QoQ); Analyst estimates falling over recent quarters
Get the Full PHG Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime